A statement of changes in beneficial ownership filed on August 13, 2026 disclosed that Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., sold 1,140 shares of common stock on August 11, 2026.

Key Highlights

  • Reporting person: Cornelius P. McCarthy III, identified as a Director of Medpace Holdings, Inc.
  • Transaction: 1,140 shares of common stock disposed of (transaction code S) on August 11, 2026
  • Sale price: $605.37 per share
  • Remaining ownership: 12,275 shares of common stock held directly following the transaction
  • Filing date: August 13, 2026, signed by Stephen P. Ewald as attorney-in-fact for McCarthy

Director Share Sale at Medpace Holdings Reported to Regulators

According to the filing, Cornelius P. McCarthy III, a director at Medpace Holdings, Inc. (NASDAQ:MEDP), sold 1,140 shares of the company's common stock on August 11, 2026 at a price of $605.37 per share. The transaction is coded "S," indicating an open-market sale, and was reported as a direct disposition. Medpace Holdings is a Cincinnati, Ohio-based clinical research organization, with its address listed in the filing as 5375 Medpace Way, Cincinnati, Ohio 45227.

Following the reported sale, McCarthy's directly held position in Medpace Holdings common stock stood at 12,275 shares, according to the filing. No derivative securities were reported in connection with this filing, and Table II of the form contained no entries. The filing was signed on August 13, 2026 by Stephen P. Ewald, acting as attorney-in-fact for Cornelius P. McCarthy III. No amendment date was noted, indicating this was an original filing rather than a correction to a prior report.

What Was Disclosed

The filing reported a single open-market sale of 1,140 shares of Medpace Holdings common stock by director Cornelius P. McCarthy III at $605.37 per share on August 11, 2026, leaving him with a directly held position of 12,275 shares.